tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ATRA is currently covered by 2 analysts with an average price target of $15.5. This is a potential upside of $13.42 (65.25%) from yesterday's end of day stock price of $9.38.
Atara Biotherapeutics's activity chart (see below) currently has 27 price targets and 37 ratings on display. The stock rating distribution of ATRA is 66.67% BUY and 33.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 62.61% with an average time for these price targets to be met of 268.26 days.
Highest price target for ATRA is $18, Lowest price target is $13, average price target is $15.5.
Most recent stock forecast was given by from CANACCORD on 08-May-2026. First documented stock forecast 03-Dec-2015.
Currently out of the existing stock ratings of ATRA, 2 are a BUY (66.67%), 1 are a HOLD (33.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-May-2026
$13
$2.49 (23.69%)
$6
Buy Since 18-Aug-2025
$18
$7.49 (71.27%)
$16
Hold Since 02-Nov-2023
$5
$-5.51 (-52.43%)
$10
Buy Since 04-Jan-2021
$25
$14.49 (137.87%)
What is ATRA (Atara Biotherapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ATRA (Atara Biotherapeutics) with a proven track record?
Which analyst has the most public recommendations on ATRA (Atara Biotherapeutics)?
Which analyst is the currently most bullish on ATRA (Atara Biotherapeutics)?
Which analyst is the currently most reserved on ATRA (Atara Biotherapeutics)?
